FT Big Read

Medical science: Cancer challenge

FT Big Read

Can remarkable science be turned into mass-market products, asks David Crow. Cell therapies to treat blood cancers offer hope to patients who have exhausted all other possibilities and are likely to get regulatory approval this year. But they are expensive and production is time consuming, says David. The process needs to be streamlined and capacity matched to demand

Hosted on Acast. See acast.com/privacy for more information.

Next Episodes

FT Big Read

Real estate: The global luxury condo glut @ FT Big Read

📆 2017-06-08 17:25 / 00:13:10


FT Big Read

Is China heading for a Japanese-style bubble? @ FT Big Read

📆 2017-05-31 18:44 / 00:14:44


FT Big Read

Brazil: The poison of corruption @ FT Big Read

📆 2017-05-26 15:39 / 00:15:25


FT Big Read

Iranian presidential election: The blame game @ FT Big Read

📆 2017-05-16 18:02 / 00:14:49


FT Big Read

Europe: a welcome reprieve from populism @ FT Big Read

📆 2017-05-12 19:55 / 00:10:49